(5R)-3-[3-fluoro-4-[6-[(5S)-5-[[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3-pyridinyl]phenyl]-5-(triazol-1-ylmethyl)-1,3-oxazolidin-2-one

C28H31FN8O5 — CID 11541525

IUPAC(5R)-3-[3-fluoro-4-[6-[(5S)-5-[[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3-pyridinyl]phenyl]-5-(triazol-1-ylmethyl)-1,3-oxazolidin-2-one
SMILESCN1CCN(C(=O)COC[C@@H]2CC(c3ccc(-c4ccc(N5C[C@H](Cn6ccnn6)OC5=O)cc4F)cn3)=NO2)CC1
InChIInChI=1S/C28H31FN8O5/c1-34-8-10-35(11-9-34)27(38)18-40-17-21-13-26(32-42-21)25-5-2-19(14-30-25)23-4-3-20(12-24(23)29)37-16-22(41-28(37)39)15-36-7-6-31-33-36/h2-7,12,14,21-22H,8-11,13,15-18H2,1H3/t21-,22-/m0/s1
InChIKeyGOVANZYIRPMNBE-VXKWHMMOSA-N
MW578.61 g/mol
LogP1.79
Rot. Bonds9

About (5R)-3-[3-fluoro-4-[6-[(5S)-5-[[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3-pyridinyl]phenyl]-5-(triazol-1-ylmethyl)-1,3-oxazolidin-2-one

(5R)-3-[3-fluoro-4-[6-[(5S)-5-[[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3-pyridinyl]phenyl]-5-(triazol-1-ylmethyl)-1,3-oxazolidin-2-one (PubChem CID 11541525) has the molecular formula C28H31FN8O5 and a molecular weight of 578.61 g/mol. Its IUPAC name is (5R)-3-[3-fluoro-4-[6-[(5S)-5-[[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3-pyridinyl]phenyl]-5-(triazol-1-ylmethyl)-1,3-oxazolidin-2-one.

Molecular Properties

Compound Name(5R)-3-[3-fluoro-4-[6-[(5S)-5-[[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3-pyridinyl]phenyl]-5-(triazol-1-ylmethyl)-1,3-oxazolidin-2-one
PubChem CID11541525
Molecular FormulaC28H31FN8O5
Molecular Weight578.61 g/mol
Exact Mass578.24
IUPAC Name(5R)-3-[3-fluoro-4-[6-[(5S)-5-[[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3-pyridinyl]phenyl]-5-(triazol-1-ylmethyl)-1,3-oxazolidin-2-one
SMILESCN1CCN(C(=O)COC[C@@H]2CC(c3ccc(-c4ccc(N5C[C@H](Cn6ccnn6)OC5=O)cc4F)cn3)=NO2)CC1
InChIInChI=1S/C28H31FN8O5/c1-34-8-10-35(11-9-34)27(38)18-40-17-21-13-26(32-42-21)25-5-2-19(14-30-25)23-4-3-20(12-24(23)29)37-16-22(41-28(37)39)15-36-7-6-31-33-36/h2-7,12,14,21-22H,8-11,13,15-18H2,1H3/t21-,22-/m0/s1
InChIKeyGOVANZYIRPMNBE-VXKWHMMOSA-N
XLogP1.79
TPSA127.51 Ų
H-Bond Donors
H-Bond Acceptors11
Rotatable Bonds9
Heavy Atoms42
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500578.61
LogP ≤ 51.79
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1011

Analyze (5R)-3-[3-fluoro-4-[6-[(5S)-5-[[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3-pyridinyl]phenyl]-5-(triazol-1-ylmethyl)-1,3-oxazolidin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (5R)-3-[3-fluoro-4-[6-[(5S)-5-[[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3-pyridinyl]phenyl]-5-(triazol-1-ylmethyl)-1,3-oxazolidin-2-one?
The IUPAC name of (5R)-3-[3-fluoro-4-[6-[(5S)-5-[[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3-pyridinyl]phenyl]-5-(triazol-1-ylmethyl)-1,3-oxazolidin-2-one (CID 11541525) is (5R)-3-[3-fluoro-4-[6-[(5S)-5-[[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3-pyridinyl]phenyl]-5-(triazol-1-ylmethyl)-1,3-oxazolidin-2-one.
What is the SMILES notation for (5R)-3-[3-fluoro-4-[6-[(5S)-5-[[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3-pyridinyl]phenyl]-5-(triazol-1-ylmethyl)-1,3-oxazolidin-2-one?
The canonical SMILES for (5R)-3-[3-fluoro-4-[6-[(5S)-5-[[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3-pyridinyl]phenyl]-5-(triazol-1-ylmethyl)-1,3-oxazolidin-2-one is CN1CCN(C(=O)COC[C@@H]2CC(c3ccc(-c4ccc(N5C[C@H](Cn6ccnn6)OC5=O)cc4F)cn3)=NO2)CC1.
What is the InChIKey of (5R)-3-[3-fluoro-4-[6-[(5S)-5-[[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3-pyridinyl]phenyl]-5-(triazol-1-ylmethyl)-1,3-oxazolidin-2-one?
The InChIKey is GOVANZYIRPMNBE-VXKWHMMOSA-N. The full InChI is InChI=1S/C28H31FN8O5/c1-34-8-10-35(11-9-34)27(38)18-40-17-21-13-26(32-42-21)25-5-2-19(14-30-25)23-4-3-20(12-24(23)29)37-16-22(41-28(37)39)15-36-7-6-31-33-36/h2-7,12,14,21-22H,8-11,13,15-18H2,1H3/t21-,22-/m0/s1.
What are the key properties of (5R)-3-[3-fluoro-4-[6-[(5S)-5-[[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3-pyridinyl]phenyl]-5-(triazol-1-ylmethyl)-1,3-oxazolidin-2-one?
(5R)-3-[3-fluoro-4-[6-[(5S)-5-[[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3-pyridinyl]phenyl]-5-(triazol-1-ylmethyl)-1,3-oxazolidin-2-one has a molecular weight of 578.61 g/mol, XLogP of 1.79, 9 rotatable bonds, 0 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for (5R)-3-[3-fluoro-4-[6-[(5S)-5-[[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3-pyridinyl]phenyl]-5-(triazol-1-ylmethyl)-1,3-oxazolidin-2-one is sourced from PubChem (CID 11541525), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).